Gisela Robles Aguilar
Global Burden of Disease Researcher
Gisela joined GRAM as a Global Burden of Disease Researcher in 2018, and she supports efforts to estimate the burden of antimicrobial resistance worldwide and inform public health decision-making at the local and international levels. In the last three years, Gisela has collaborated with the Lancet Noncommunicable Diseases and Injuries (NCDIs) Poverty Commission by profiling risk factors to NCDIs across the poorest populations in the World, applying methodologies utilised by the Institute of Health Metrics (IHME) in its ongoing Global Burden of Disease (GBD) study. Gisela has also served as a Data Analyst at Oxford’s Clinical Trials Service Unit and Research Officer at the Oxford Poverty and Human Development Initiative (OPHI).
Gisela received her DPhil in Social Policy from Oxford in 2014, with a focus on modelling participation in conditional cash transfers.
Recent publications
-
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet, 404, 1199 - 1226
-
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
IHME Pathogen Core Group None., (2024), Lancet Infect Dis
-
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418
-
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators None., (2023), Lancet Reg Health Am, 25
-
The burden of bacterial antimicrobial resistance in Croatia in 2019: a country-level systematic analysis.
Meštrović T. et al, (2023), Croat Med J, 64, 272 - 283